Anticoagulants Clinical Trials

16 recruitingLast updated: June 18, 2026

There are 16 actively recruiting anticoagulants clinical trials across 9 countries. Studies span Not Applicable, Phase 4. Top locations include Amsterdam, Netherlands, Arnhem, Netherlands, Beijing, Beijing Municipality, China. Updated daily from ClinicalTrials.gov.


Anticoagulants Trials at a Glance

16 actively recruiting trials for anticoagulants are listed on ClinicalTrialsFinder across 6 cities in 9 countries. The largest study group is Not Applicable with 6 trials, with the heaviest enrollment activity in Amsterdam, Arnhem, and Beijing. Lead sponsors running anticoagulants studies include Centre Hospitalier Régional d'Orléans, Combined military hospital lahore, and Brigham and Women's Hospital.

Browse anticoagulants trials by phase

Treatments under study

About Anticoagulants Clinical Trials

Looking for clinical trials for Anticoagulants? There are currently 5 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Anticoagulants trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Anticoagulants clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 116 of 16 trials

Recruiting
Phase 4

AntiPlatelet theraPy stratEgy followiNg Left Atrial appenDAGe closurE

Atrial FibrillationStrokePlatelet Aggregation Inhibitors+2 more
University Hospital, Bordeaux60 enrolled2 locationsNCT04796714
Recruiting
Not Applicable

Catheter Ablation Plus LAAO Versus Anticoagulation in Frail Elderly Patients With Atrial Fibrillation

StrokeFrailtyAtrial Fibrillation (AF)+4 more
Guangdong Provincial People's Hospital200 enrolled1 locationNCT07441382
Recruiting
Not Applicable

Comparison Between Direct Oral Anticoagulation (DOAC) Interruption and DOAC Continuation in Patients Undergoing Elective Invasive Coronary Angiography or Percutaneous Coronary Intervention

Atrial FibrillationCoronary Artery DiseaseAnticoagulants
Zuyderland Medisch Centrum1,270 enrolled1 locationNCT04977076
Recruiting

International Registry of Thrombotic APS Patients Treated With Direct Oral Anticoagulants

ThrombosisAntiphospholipid SyndromeAnticoagulants Causing Adverse Effects in Therapeutic Use
Stéphane Zuily500 enrolled1 locationNCT04262492
Recruiting

CLOT-LESS - CLOsure Tailored: LEss Antithrombotic Strategy After LAAC for Stroke Prevention

Atrial FibrillationThromboembolismLeft Atrial Appendage Closure+4 more
National Medical Research Center for Therapy and Preventive Medicine464 enrolled1 locationNCT07575867
Recruiting
Not Applicable

Effect of Apiban Therapy on AVF Maturation in ESRD Patients

Arteriovenous FistulaDirect Oral Anticoagulants (DOACs)Endstage Renal Disease+1 more
Combined military hospital lahore190 enrolled1 locationNCT07559942
Recruiting

Oral Biopsy Bleeding in Patients on Direct Oral Anticoagulants (DOACs)

Oral Surgical ProceduresDirect Oral Anticoagulants (DOACs)
University of Pisa100 enrolled1 locationNCT07520890
Recruiting
Not Applicable

Home Hospital for Suddenly Ill Adults

Heart FailureAsthmaChronic Kidney Diseases+6 more
Brigham and Women's Hospital3,000 enrolled2 locationsNCT03524222
Recruiting

Hip Fracture Surgery Timing and Blood Transfusion Risk in Patients on DOACs

blood transfusionBlood Transfusion ComplicationBleeding+6 more
St. Antonius Hospital374 enrolled7 locationsNCT07309848
Recruiting
Not Applicable

Comparison of Heparin Anti-Xa Activity From Central Venous Catheter Samples Using a 5 mL Syringe Flush or a Vacuum Tube Flush Versus Peripheral Vein Samples in ICU Patients

Anticoagulants and Bleeding Disorders
Centre Hospitalier Régional d'Orléans30 enrolled1 locationNCT07183605
Recruiting
Phase 4

Anticoagulation Profile in Pregnant Women Treated With Three Times a Day of Low Molecular Weight Heparin (LMWH)

Pregnancy, High RiskAnticoagulants
University of California, Irvine12 enrolled1 locationNCT04861103
Recruiting

Prospective Observational Pilot Study of LMWH Versus UFH as ECMO Anticoagulation in Lung Transplantation

Extracorporeal Membrane Oxygenation (ECMO)Anticoagulants and Bleeding DisordersLung transplantation
University Hospital, Motol40 enrolled1 locationNCT06868823
Recruiting
Not Applicable

Shared Decision for Drug Interactions in Oral Anticoagulation

Anticoagulantsdrug interactions
University of Utah3,691 enrolled3 locationsNCT06401863
Recruiting

Safety and Efficacy of Edoxaban and Rivaroxaban to Cerebral Venous Thrombosis in Chinese Patients

Anticoagulant TherapyCerebral Venous ThrombosisAnticoagulant Drugs+6 more
Xuanwu Hospital, Beijing1,486 enrolled1 locationNCT06947707
Recruiting

Caudal Analgesia & Anticoagulated Patient

Lumbar Pain SyndromeAnticoagulants and Bleeding Disorders
Salem Anaesthesia Pain Clinic100 enrolled1 locationNCT05946850
Recruiting

Personalized Anticoagulant Therapy for Pulmonary Thromboembolism

Pulmonary ThromboembolismsAnticoagulants; Increased
Xiangya Hospital of Central South University4,700 enrolled1 locationNCT06341231